SPDR S&P Pharmaceuticals ETF
State Street Corp. XPH ETF
XPH Price | $43.54 |
Market Cap | $159.82M |
Annual Dividend Yield | 1.56% |
Annual Dividend | $0.70 |
Yearly Management Fee | 0.35% |
Asset Class | Equity |
Focus | Health care |
Category | Sector, Health Care |
Niche | Pharmaceuticals |
Last 24h Volume | $28.98K |
Portfolio Management Company | State Street Corp. |
Discount/Premium to NAV | 0.09% |
Inception Date | Jun 19, 2006 |
Market Cap Rank | 1711 |
Monthly AUM Growth | 1.24% |
Holdings Region | North America |
Management Style | Passive |
Leverage | Non-Leveraged |
SPDR S&P Pharmaceuticals ETF is an ETF issued by State Street Corp. on Jun 19 2006.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of XPH ETF according to its net asset value is premiumed at 0.09%.
While the total value of the fund shows $1.96M increase compared to the previous month, its price is traded daily at a decrease of -2.51%.
The annual dividend yield of XPH ETF is 1.56%, whereas its main asset area is North America.
XPH ETF, whose 24-hour total volume is $28.98K, has experienced a $4.37M cash inflow in the last month.
In addition, SPDR S&P Pharmaceuticals ETF's one-year net asset value total return is 11.55%.
XPH ETF Returns
Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
-2.51% |
-4.27% |
-3.61% |
-4.01% |
8.85% |
5.91% |
8.99% |
XPH ETF NAV Total Return
Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
-0.42% |
-0.99% |
8.58% |
11.55% |
3.50% |
5.42% |
XPH ETF Comments
no comments yet